跳至主要内容
临床试验/NCT05446116
NCT05446116已完成不适用

Transfemoral Versus Transradial Partial Splenic Artery Embolization in Patients With Hypersplenism, a Randomized Controlled Trial

Zagazig University1 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2019年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
112
试验地点
1
主要终点
X-ray exposure duration

研究概览

简要总结

The present study aimes at comparing the transradial and transfemoral approaches for partial splenic embolization in patients with hypersplenism.

详细描述

Since its development in 1979, partial splenic embolization (PSE) has been universally accepted to treat patients with hypersplenism in preference to surgical splenectomy. The spleen is the primary source of antibodies, lymphocyte production, and responsible for phagocytosis of white cells. Additionally, it plays an essential role in the immune system. Unlike splenectomy, partial splenic embolization (PSE) maintained partial splenic function and was thought to be an effective alternative to treat thrombocytopenia and leukopenia resulted from hypersplenism with fewer complications.

PSE is usually performed using a femoral artery approach that requires bed rest for a few hours. Recently, the transradial approach, with less obvious need for bed rest, has been more widely applied for cardiovascular intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with hypersplenism and severe thrombocytopenia (platelet count < 50,000/mm3).
  • the functional status of the liver should be Child A or early B according to Child-Pugh classification (5-7 points) (albumin ≥ 2.8 g/dL, bilirubin ≤ 3 mg/dL, prothrombin time ≤ 4 or INR < 1.7, no ascites, no encephalopathy).
  • Eligible for both femoral and radial puncture.

排除标准

  • Patients referred for embolization as treatment of traumatic splenic injury.
  • Patients lost during follow-up.

结局指标

主要结局

X-ray exposure duration

时间窗: Immediately after the procedure is complete

Duration of flouroscopy exposure during the procedure

Procedural time

时间窗: Immediately after the procedure is complete

The time interval from starting the anaethesia till completion of the procedure

Average number of punctures

时间窗: Immediately after the procedure is complete

Number of arterial punctures required to complete the procedure

Technical Success of the Procedure

时间窗: Immediately after the procedure is complete

The achievement of a single puncture allowing access to splenic artery without periprocedural complications.

Length of hospital stay

时间窗: 7 days

Number of days that the patient will spend in the hospital after the procedure.

Complications at access site

时间窗: 30 days

Access site adverse events such as vessel thrombosis, pseudoaneurysm or bleeding.

次要结局

  • Procedural complications(30 days)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Mohamed M.A. Zaitoun

Associate Professor

Zagazig University

研究点 (1)

Loading locations...

相似试验